Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
48

Summary

Conditions
Peanut Allergy
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 6 years and 17 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03793608
Collaborators
Sanofi
Investigators
Study Director: Clinical Trial Management Regeneron Pharmaceuticals